Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00660803

Enrollment

200

Registered

2008-04-17

Start date

2008-05-31

Completion date

2009-04-30

Last updated

2010-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Advanced Breast Cancer, Hormone Therapy

Brief summary

Characterize the demographic and clinical features, as well as the main treatment results, among patients with advanced breast cancer treated with fulvestrant in Brazil.

Interventions

DRUGFulvestrant

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Positive HR or ER by immunohistochemistry * Postmenopausal status at the time of treatment with fulvestrant * Failure of at least one previous endocrine therapy before treatment with fulvestrant.

Exclusion criteria

* Patients who are still undergoing treatment with fulvestrant will not be eligible to participate in the study

Design outcomes

Primary

Measure	Time frame
Time to tumour progression	—
Objective response	—

Secondary

Measure	Time frame
Duration of treatment with fulvestrant	—
Time and duration of response	—
Overall survival	—

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026